Key Segments:
By Drug Type
-
Small Molecules
-
Biologics
By Therapeutic Area
-
Oncology
-
Neurology and CNS Disorders
-
Infectious Diseases
-
Cardiovascular Diseases
-
Metabolic Disorders
-
Other Therapeutic Areas
By Route of Administration
-
Oral
-
Intravenous
-
Other Routes of Administration
By End Use
-
Pharmaceutical and Biopharmaceutical Companies
-
Contract Research Organizations (CROs)
-
Other End Uses
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Poland
-
Russia
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Key players in the Drug Repurposing Market include AbbVie Inc., Amgen Inc., Boehringer Ingelheim International GmbH, Eli Lilly and Company, and Novartis AG, among others.
Key opportunities in the Drug Repurposing Market include increasing use of artificial intelligence for drug discovery, expansion of rare disease research, and growing demand for cost-effective treatment development.
The market is driven by increasing demand for faster and cost-effective drug development, along with rising investments in artificial intelligence and computational drug discovery.
The Small Molecules segment dominated the Drug Repurposing Market, accounting for approximately 67.00% market share.
The North America region dominated the Drug Repurposing Market in 2025 with a 39.00% share, driven by high firearm sales and strong defense procurement.
